Viewing nowCombinationJanuprep Tablet 10/100 mg
Dapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.

MFDS item code 202300259 · Approved 2023.01.16 · Insurance code 678601990
Improvement in blood sugar control
This medication is used to assist in the control of blood sugar levels in patients with type 2 diabetes who require a combination of sitagliptin and dapagliflozin. When taken alongside dietary and exercise therapy, it helps effectively improve blood sugar levels. Therefore, this medication plays an important role in the management of blood sugar in patients with type 2 diabetes.
For patients receiving sitagliptin 100 mg and dapagliflozin 10 mg, the dosage is one tablet administered once daily regardless of meals. The tablet should be swallowed whole.
This medication may cause serious allergic reactions within the first 3 months of administration; if symptoms such as skin rash or difficulty breathing occur, discontinue use immediately and consult your physician. While taking this medication, there is a risk of developing pancreatitis, a serious inflammation of the pancreas; if symptoms such as abdominal pain, vomiting, or fever occur, inform healthcare professionals immediately. This medication should not be used in patients with allergies to specific components, type 1 diabetes, diabetic ketoacidosis, or those undergoing dialysis. Particular caution is necessary in patients with impaired kidney function, reduced fluid volume, and the elderly; dosage adjustments and regular monitoring of kidney function should be conducted according to physician's guidance. During treatment, genital infections or urinary tract infections may occur, and active treatment should be sought upon the appearance of signs of infection. This medication may induce hypoglycemia; caution is required when taken with insulin or other hypoglycemic agents, and dosage adjustments may be necessary if hypoglycemic symptoms arise. Symptoms of hypotension or dehydration due to reduced fluid volume may occur; especially in the elderly or those on diuretics, blood pressure and fluid status should be monitored periodically. This medication is not recommended for women who are pregnant or breastfeeding; if pregnancy is confirmed, discontinue use immediately. Safety and efficacy have not been established in children and adolescents under 18 years of age; therefore, use is not advised. In case of overdose, there is no specific antidote; appropriate treatment should be administered according to symptoms, and monitoring in a hospital may be necessary. Care is required when driving or operating machinery, particularly if hypoglycemic symptoms are present; such activities should be avoided.
Urticaria, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, paleness, anaphylaxis, angioedema, Stevens-Johnson syndrome, severe hypersensitivity reactions, severe rash with high fever, blistering, skin sloughing, mucosal pain in mouth/eyes, acute pancreatitis, fatal/non-fatal hemorrhagic or necrotizing pancreatitis, respiratory issues, shortness of breath or difficulty breathing, asthma attacks, cough with fever accompanied respiratory distress, skin rash
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to protect it from air and moisture. It is recommended to maintain a storage temperature between 1 to 30 degrees Celsius.
Beige oval film-coated tablet
30 tablets/PTP [(10 tablets/PTP x 3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Daewoo Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
International Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Shinpoong Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
IYON Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Kujoo Pharmaceutical Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.